Clinical Trial Update: Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating eltrombopag to initiate and maintain interferon antiviral treatment in subjects with chronic hepatitis C-related liver disease; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Promacta (eltrombopag)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis C, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2012-07-30